Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.41 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.41 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | PLG | P00747 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22559996 | 0.79 | CYP3A4 (0.44) | HDAC8DDB1CRBNPOLB | |
| SCHEMBL23477961 | 0.79 | CYP3A4 (0.44) | HDAC8DDB1CRBNPOLB | |
| SCHEMBL2135826 | 0.78 | DDB1 (0.41) | HDAC8DDB1CRBN | |
| SCHEMBL8922877 | 0.72 | PLG (0.39) | HDAC8DDB1CRBNPOLBPLG | |
| SCHEMBL12888152 | 0.72 | CYP26A1 (0.37) | HDAC8DDB1CRBNMAOB | |
| SCHEMBL7385157 | 0.72 | HDAC8 (0.47) | HDAC8DDB1CRBNPOLB | |
| SCHEMBL7385153 | 0.72 | HDAC8 (0.47) | HDAC8DDB1CRBNPOLB | |
| SCHEMBL13428073 | 0.71 | HDAC8 (0.55) | HDAC8POLB | |
| SCHEMBL13323325 | 0.71 | HDAC8 (0.55) | HDAC8POLB | |
| SCHEMBL22295471 | 0.71 | CYP26A1 (0.39) | DDB1CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0882022-A1 | ASPARTYL PROTEASE INHIBITORS | Vertex Pharmaceuticals Incorporated (US) | 1998-12-09 | — | — | EP | disclosed |
| WO-1997027180-A1 | ASPARTYL PROTEASE INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1997-07-31 | — | — | WO | disclosed |